Literature DB >> 11273351

Coenzyme Q in cardiovascular disease.

R B Singh1, M A Niaz, V Rastogi, S S Rastogi.   

Abstract

Coenzyme Q10 or ubiquinone normally present in many plant and animal cells is an antioxidant. Coenzyme Q10 deficiency has been observed in patients with congestive heart failure, angina pectoris, coronary artery disease, cardiomyopathy, hypertension, mitral valve prolapse and after coronary revascularization. Coenzyme Q10 is involved in the synthesis of ATP and hence is useful in preventing cellular damage during ischaemia-reperfusion injury. The clinical benefits are mainly due to its ability to improve energy production, antioxidant activity, and membrane stabilizing properties. Several studies showed that coenzyme Q could be useful in patients with congestive heart failure, angina pectoris, cardiomyopathy, coronary artery disease and in the preservation of myocardium. Coenzyme Q10 is normally present in the low density lipoprotein cholesterol fraction and inhibits its oxidation. It can also regenerate vitamin E. Coenzyme Q10 is known for producing minor gastrointestinal discomfort and elevation in SGOT and LDH when used.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 11273351

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  3 in total

Review 1.  An experimental approach to study the function of mitochondria in cardiomyopathy.

Authors:  Youn Wook Chung; Seok-Min Kang
Journal:  BMB Rep       Date:  2015-10       Impact factor: 4.778

2.  The Protective Effects of Coenzyme Q10 and Lisinopril Against Doxorubicin-Induced Cardiotoxicity in Rats: A Stereological and Electrocardiogram Study.

Authors:  Maryam Rahmanifard; Mahmood Vessal; Ali Noorafshan; Saied Karbalay-Doust; Maryam Naseh
Journal:  Cardiovasc Toxicol       Date:  2021-08-02       Impact factor: 3.231

3.  Metabolic Pathway Genes Associated with Susceptibility Genes to Coronary Artery Disease.

Authors:  Heng Lu; Yi Chen; Linlin Li
Journal:  Int J Genomics       Date:  2018-02-11       Impact factor: 2.326

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.